High dose thiotepa

WebHigh-dose therapy (HDTx) with autologous stem cell rescue has been widely applied in very-poor-risk pediatric solid tumors. Promising data have become available with the use … WebThe usual melphalan dose is 200 mg/m 2, although a ‘risk-adapted’ approach, with dose reduction to 140 mg/m 2 used in higher-risk patients in order to reduce transplant-related toxicity. r Criteria for defining ‘high-risk’ patients are; age >60, increased creatinine level, performance status (PS) 2 or compensated cardiac failure.

Thiotepa-Based High-Dose Chemotherapy With Autologous …

Web12 de abr. de 2024 · GvHD prophylaxis comprised of PTCy 50 mg/kg/day on days +3 and +4, oral mycophenolate (MMF) 15 mg/kg/dose every 8 h from day +5 to +35, and sirolimus from day +5 onwards (goal 5–15 ng/mL). Web16 de nov. de 2015 · High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma. Hematology 2012; 17 : 23–27. fishing port sulphur la https://cashmanrealestate.com

Phase 2 trial of high‐dose rituximab with high‐dose cytarabine ...

Web3 de nov. de 2024 · Thiotepa, a myeloablative, high-dose chemotherapeutic (HDT) treatment administered prior to autologous hematopoietic stem cell transplantation … Web12 de set. de 2024 · Thiotepa was approved for use in the United States in 1959. Current indications include ovarian and breast cancer and Hodgkin disease. Thiotepa is also administered locally for bladder cancer, … WebThiotepa is also used with high-dose chemotherapy with HPCT support to treat certain solid tumors in adult and children. Thiotepa is used in the palliation of many neoplastic diseases. The best results are found in the treatment of adenocarcinoma of the breast, adenocarcinoma of the ovary, papillary thyroid cancer and bladder cancer. fishing port wakefield shop

Phase 2 trial of high‐dose rituximab with high‐dose cytarabine ...

Category:Autologous conditioning high dose melphalan 140 mg/m 2

Tags:High dose thiotepa

High dose thiotepa

Conditioning regimens for hematopoietic cell transplantation: …

Web17 de jul. de 2014 · Although full consensus has not been reached within the HCT community, conditioning regimens have been classified as high-dose (myeloablative), reduced-intensity, and nonmyeloablative, following the Reduced-Intensity Conditioning Regimen Workshop, convened by the Center for International Blood and Marrow … WebBackground: Autologous stem cell transplantation (ASCT) generally provides good results in Hodgkin's lymphoma (HL). We studied a high-dose chemotherapy regimen based on …

High dose thiotepa

Did you know?

WebSince, IOV of both thioTEPA and TEPA was equal to or smaller than IIV, therapeutic drug monitoring based on data of previous courses may be meaningful using this population model. AIMS To study the population pharmacokinetics of thioTEPA and its main metabolite TEPA in patients receiving high-dose chemotherapy consisting of thioTEPA (80-120 mg … Web20 de out. de 2024 · Very few prospective studies have been conducted in this patient group. This study was a multicenter phase 1/2 study that investigated thiotepa in combination with ifosfamide, etoposide, and rituximab (TIER) for the treatment of PCNSL relapsed or refractory to high-dose methotrexate-based chemotherapy.

WebHigh-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, … WebProspective studies of intensive chemotherapy regimens containing high-dose methotrexate, followed by hematopoietic stem cell transplantation have shown the most favorable outcomes, especially for patients receiving thiotepa-based …

Web2 de nov. de 2015 · No toxicity-related death was associated with high-dose (HD) thiotepa. The median hospital stay was 24 days (range 19–49). HD busulfan–melphalan (n=24) WebHigh-dose thioTEPA is used frequently in myeloablative regimens for marrow transplantation, but the need for dose adjustments in obese patients has not been …

Web19 de abr. de 2004 · Children with high-risk and recurrent brain tumors currently have a poor prognosis. 1-5 To increase brain distribution of antitumor drugs that do not cross the …

Web21 de set. de 2024 · Thiotepa side effects. Get emergency medical help if you have signs of an allergic reaction: hives; wheezing, difficult breathing; swelling of your face, lips, … can cats get meningitisWeb19 de abr. de 2004 · Children with high-risk and recurrent brain tumors currently have a poor prognosis. 1-5 To increase brain distribution of antitumor drugs that do not cross the blood-brain barrier at conventional dosages and to achieve higher concentrations within the tumor, high-dose chemotherapy (HDCT) followed by autologous hemopoietic stem cell … can cats get lyme disease from fleasWeb21 de set. de 2016 · Alkylating agents have been shown to be active against both CNS and systemic GCTs 27 and given that their dose-limiting toxicity is primarily hematologic, these are attractive agents for high-dose therapy followed by ASCR. Thiotepa, 28 specifically, has been shown to cross the blood-brain barrier extremely efficiently and has a mild … can cats get mercury poisoning from tunaWeb15 de ago. de 2024 · High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with … can cats get meningitis from humansWeb21 de set. de 2016 · Stewart DA, Forsyth P, Chaudhry A, et al: High dose thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic stem cell transplantation (ASCT) without whole brain radiotherapy (WBRT) for primary central nervous system lymphoma (PCNSL). Blood (ASH Annual Meeting Abstracts) 104:: 4315, 2004, (abstr … can cats get mites from birdsWebPrzepiorka D, Nath R, Ippoliti C, Mehra R, Hagemeister F, Diener K, Dimopoulos M, et al. A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma. Leuk Lymphoma. 1995; 17:427–33. [Abstract: 7549833] fishing postersWeb9 de set. de 2014 · Therefore, high-dose rituximab was combined with TBC for ASCT in patients with CNS NHL. METHODS. A single-arm phase 2 trial using high-dose rituximab with cytarabine for stem cell mobilization followed by high-dose rituximab combined with thiotepa, busulfan, and cyclophosphamide (R-TBC) for ASCT was conducted. fishingpost